These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Effectiveness and tolerance of amlodipine in treatment of patients with mild to moderate hypertension. Results of a long-term study with a new calcium antagonist]. Habeler G; Lenzhofer R; Pall H; Tomaschek A; Ziebart-Schroth A; Zirm B; Ganzinger U Wien Klin Wochenschr; 1992; 104(1):16-20. PubMed ID: 1532108 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of amlodipine in patients with mild-to-moderate hypertension. Olvera R; Samaniego V; Moguel R; Meaney E Int J Clin Pharmacol Res; 1991; 11(5):237-41. PubMed ID: 1839988 [TBL] [Abstract][Full Text] [Related]
24. Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone. Daniels AR; Opie LH Am J Cardiol; 1986 Apr; 57(11):965-70. PubMed ID: 3515899 [TBL] [Abstract][Full Text] [Related]
25. Comparison of nisoldipine and atenolol in the treatment of essential hypertension. Takahashi H; Fukuyama M; Yoneda S; Okabayashi H; Yoshimura M Arzneimittelforschung; 1989 Mar; 39(3):379-82. PubMed ID: 2667523 [TBL] [Abstract][Full Text] [Related]
26. Working ability and exercise tolerance during treatment of a mild hypertension. I. Comparison between a beta-adreno-receptor blocking drug and a calcium antagonist. Lange Andersen K; Piatkowski W; Green KA; Ottmann W Int Arch Occup Environ Health; 1985; 56(1):41-7. PubMed ID: 2863220 [TBL] [Abstract][Full Text] [Related]
27. Amlodipine versus atenolol in essential hypertension. Frishman WH; Brobyn R; Brown RD; Johnson BF; Reeves RL; Wombolt DG Am J Cardiol; 1994 Jan; 73(3):50A-54A. PubMed ID: 8310977 [TBL] [Abstract][Full Text] [Related]
28. A double-blind evaluation of the effect of amlodipine on ambulatory blood pressure. Mroczek WJ; Burris JF; Klein J Postgrad Med J; 1991; 67 Suppl 5():S24-7. PubMed ID: 1839434 [TBL] [Abstract][Full Text] [Related]
29. Combination therapy with beta-adrenergic blockade and amlodipine as second line treatment in essential hypertension. Mettimano M; Pichetti F; Fazzari L; Migneco A; Specchia L; Romano Spica V; Savi L Int J Clin Pract; 2000 Sep; 54(7):424-8. PubMed ID: 11070565 [TBL] [Abstract][Full Text] [Related]
30. Comparative effects of felodipine ER, amlodipine and nifedipine GITS on 24 h blood pressure control and trough to peak ratios in mild to moderate ambulatory hypertension: a forced titration study. Lefebvre J; Poirier L; Archambault F; Jewell D; Reed CV; Lacourcière Y Can J Cardiol; 1998 May; 14(5):682-8. PubMed ID: 9627524 [TBL] [Abstract][Full Text] [Related]
31. Clinical evaluation of amlodipine, a new long-acting calcium antagonist, in mild and moderate hypertension. Escudero J; Hernandez H Int J Clin Pharmacol Res; 1991; 11(5):243-6. PubMed ID: 1839989 [TBL] [Abstract][Full Text] [Related]
32. Comparison of controlled-onset, extended-release verapamil with amlodipine and amlodipine plus atenolol on exercise performance and ambulatory ischemia in patients with chronic stable angina pectoris. Frishman WH; Glasser S; Stone P; Deedwania PC; Johnson M; Fakouhi TD Am J Cardiol; 1999 Feb; 83(4):507-14. PubMed ID: 10073852 [TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of atenolol, nifedipine and their combination in the management of hypertension. Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID Drugs; 1988; 35 Suppl 4():29-35. PubMed ID: 3288468 [TBL] [Abstract][Full Text] [Related]
34. [A comparison between amlodipine and nifedipine retard in patients with essential arterial hypertension]. Terrachini V; Canale C; Lonati A; Masperone MA; Bruzzone F; Malvestiti FM; Caponnetto S Clin Ter; 1992 Apr; 140(4):383-9. PubMed ID: 1534044 [TBL] [Abstract][Full Text] [Related]
35. Effects of nilvadipine and amlodipine in patients with mild to moderate essential hypertension: a double blind, prospective, randomised clinical trial. Leonetti G; Curr Med Res Opin; 2005 Jun; 21(6):951-8. PubMed ID: 15969895 [TBL] [Abstract][Full Text] [Related]
36. [Atenolol/nifedipine combination: efficacy and tolerability of low dose synergistic bitherapy in the treatment of arterial hypertension]. Krivitzky A; Nguyen G; Gaudouen Y; Legrand M; Cohen R Drugs; 1998; 56 Suppl 2():31-43. PubMed ID: 9813740 [TBL] [Abstract][Full Text] [Related]
37. Atenolol and sustained release nifedipine alone and in combination in hypertension. A randomised, double-blind, crossover study. Anderton JL; Vallance BD; Stanley NN; Crowe PF; Mittra B; Perks WH Drugs; 1988; 35 Suppl 4():22-6. PubMed ID: 3288467 [TBL] [Abstract][Full Text] [Related]
38. The efficacy and tolerability of atenolol, nifedipine, and their combination in the management of hypertension. Stanley NN; Thirkettle JL; Varma MP; Larkin H; Heath ID Eur J Clin Pharmacol; 1988; 34(6):543-8. PubMed ID: 3049118 [TBL] [Abstract][Full Text] [Related]
39. [Therapy of mild to moderate hypertension. Efficacy and tolerance of Amlodipine in comparison with the combination nifedipine/mefruside]. Höfling B; Häringer E; Herrmann W; Pieske H; Pieske R; Philippi M Fortschr Med; 1991 May; 109(15):327-30. PubMed ID: 1830287 [TBL] [Abstract][Full Text] [Related]
40. Comparison of efficacy and side effects of combination therapy of angiotensin-converting enzyme inhibitor (benazepril) with calcium antagonist (either nifedipine or amlodipine) versus high-dose calcium antagonist monotherapy for systemic hypertension. Messerli FH; Oparil S; Feng Z Am J Cardiol; 2000 Dec; 86(11):1182-7. PubMed ID: 11090788 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]